Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?

Bibliography

• THE SOLVD INVESTIGATORS: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New EngL Med. (1991) 325:293–302.
   PubMed Web of Science ®Google Scholar
• COHN JN, JOHNSON G, ZIESCHE S et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New EngL J. Med. (1991) 325:303–310.
   PubMed Web of Science ®Google Scholar
• THE CONSENSUS TRIAL STUDY GROUP: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandanavian Enalapril Survival Study (CONSENSUS). New EngL J. Med. (1987) 316:1429–1435.
   PubMed Web of Science ®Google Scholar
• MERIT-HF STUDY GROUP: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet (1999) 353:2001–2007.
   PubMed Web of Science ®Google Scholar
• CIBIS-II INVESTIGATORS AND COMMITTEES: The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet (1999) 353:9–13.
   PubMed Web of Science ®Google Scholar
• PACKER M, BRISTOW M, COHN J et al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New EngL J. Med. (1996) 334:1349–1355.
   PubMed Web of Science ®Google Scholar
• ROSS J Jr, HONGO M: The role of hypertrophy and growth factors in heart failure. J. Card. Fail. (1997) 2:S121.
   Google Scholar
• ROSS J Jr, RYOKE T: Effects of growth hormone and insulin-like growth factor I in experimental heart failure. Growth Horm. IGF Res. (1998) 8:159–161.
   Google Scholar
• VOLTERRANI M, MANELLI F, CICOIRA M et al.: Role of growth hormone in chronic heart failure. Drugs (2000) 60:711–719.
   PubMed Web of Science ®Google Scholar
• ••This paper provides an excellent overviewof the potential use of GH in treating HE
   Google Scholar
• SACCX L: Growth hormone therapy for heart failure: swimming against the stream. J. Card. Fail. (1999) 5:269–275.
   PubMedGoogle Scholar
• FRYBBURG DA, GELFAND RA, BARRETT EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. PhysioL (1991) 260:E499–E504.
   PubMed Web of Science ®Google Scholar
• FRYBURG DA: Insulin-like growth factor I exerts growth hormone-and-insulin-like actions on human muscle protein. Am. J. PhysioL (1994) 267:E331–E336.
   PubMed Web of Science ®Google Scholar
• ISGAARD J, TIVESTEN A. FRIBERG P, BENGTSSON BA: The Role of GH/ IGF-1 axis for cardiac function and structure. Horm. Metab. Res. (1999) 31:50–54.
   PubMed Web of Science ®Google Scholar
• OSTERZIEL KJ, BLUM WF, STROHM 0 et al.: The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. J. Clin. End. Metab. (2000) 85:1533–1539.
   Google Scholar
• ISGAARD J, NILSSON A, VIKMAN K et al.: Growth hormone regulates the level of insulin-like growth factor I in rat skeletal muscle. J. EndocrinoL (1989) 120:107–112.
   PubMed Web of Science ®Google Scholar
• MATHEWS LS, ENBERG B, NORSTEDT G: Regulation of rat growth hormone receptor gene expression. J. Bio. Chem. (1989) 17:9905–9910.
   Google Scholar
• ITO H, HIROE M, HIRATA Y et al.: Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation (1993) 87:1715–1721.
   PubMed Web of Science ®Google Scholar
• MAYOUX E, VENTURA-CLAPIER R, TIMSIT J et al.: Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ. Res. (1993) 72:57–64.
   PubMed Web of Science ®Google Scholar
• FAZIO S, SABATINI D, CAPALDO B et al.: A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. New EngL J. Med. (1996) 334:809–814.
   PubMed Web of Science ®Google Scholar
• •This is the original paper demonstrating the potential beneficial effects of GH for the treatment of HE
   Google Scholar
• TAJIMA M, WEINBERG EO, BARTUNEK J et al.: Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation (1999) 99:127–134.
   PubMed Web of Science ®Google Scholar
• FAZIO S, CITTADINI A, BIONDI B et al.: Cardiovascular effects of short-term growth hormone hypersecretion. J. Clin. Endocrin. Metab. (2000) 85:179–182.
   PubMed Web of Science ®Google Scholar
• CUNEO RC: Editorial: GH and cardiac failure. J. Clin. EndocrinoL Metab. (2001) 86:4638–4643.
   PubMedGoogle Scholar
• ••Excellent review of the rationale forthe use of GH therapy in treating HE
   Google Scholar
• CAPALDO B, GUARDASOLE V, PARDO F et al.: Abnormal vascular reactivity in growth hormone deficiency. Circulation (2001) 103:520–524.
   PubMed Web of Science ®Google Scholar
• HORNING B, MAIER V, DREXLER H: Physical training improves endothelial function in patients with chronic heart failure. Circulation (1996) 93:210–214.
   PubMed Web of Science ®Google Scholar
• FAZIO S, CITTADINI A, BIONDI B et al.: Growth hormone as a potential future therapy for congestive heart failure. Coron. Artery Dis. (1999) 10:383–388.
   PubMed Web of Science ®Google Scholar
• DE BOER H, BLOK GJ, VAN DER VEEN EA: Clinical aspects of growth hormone deficiency in adults. End. Rev. (1995) 16:63–86.
   PubMed Web of Science ®Google Scholar
• CUNEO RC, SALOMON F, WILES CM et al.: Growth hormone treatment in growth hormone deficient adults. I. Effects on muscle mass and strength. J. AppL PhysioL (1991) 70:688–694.
   PubMed Web of Science ®Google Scholar
• CUNEO RC, SALOMON F, WILES CM et al.: Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J. AppL PhysioL (1991) 70:695–700.
   PubMed Web of Science ®Google Scholar
• FRUSTACI A, PERRONE GA, GENTOLINI N et al.: Reversible dilated cardiomyopathy due to growth hormone deficiency. Am. J. Clin. PathoL (1992) 97:503–511.
   PubMed Web of Science ®Google Scholar
• CUNEO RC, WILMHURST P, LOWY C et al.: Cardiac failure responding to growth hormone. Lancet (1989) 1:838–839.
   PubMed Web of Science ®Google Scholar
• WHITEHEAD HM, BOREHAM C, McILRATH EM et al.: Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin. EndocrinoL (1992) 36:45–52.
   PubMed Web of Science ®Google Scholar
• FRUSTACI A, GENTILONI N, RUSSO MA: Growth hormone in the treatment of dilated cardiomyopathy. New EngL J. Med. (1996) 335:672–673.
   PubMedGoogle Scholar
• YANG R, BAUNTING S, GILLETT N et al.: Growth hormone improves cardiac performance in experimental heart failure. Circulation (1995) 92:262–267.
   PubMed Web of Science ®Google Scholar
• DUERR RL, HUANG S, MIRALIAKBAR HR et al.: Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. (1995) 95:619–627.
   PubMed Web of Science ®Google Scholar
• AMBLER GR, JOHNSTON BM, MAXWELL L et al.: Improvement of doxorubicin-induced cardiomyopathy in rats treated with insulin-like growth factor-If. Cardiovasc. Res. (1993) 27:1369–1373.
   Google Scholar
• DUERR RL, McKIRNAN MD, GIM RD et al.: Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation (1996) 93:2188–2196.
   PubMed Web of Science ®Google Scholar
• JIN H, YANG R, GILLETT N et al.: Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition. J. Cardiovas. PahrmacoL (1995) 26:420–425.
   PubMed Web of Science ®Google Scholar
• SHEN Y-T, WIEDMANN RT, LYNCH JJ et al.: Growth hormone replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction. Am. J. PhysioL (1996) 271:H1721–H1726.
   Web of Science ®Google Scholar
• SHEN Y-T, WOLTMANN RF, APPLEBY S et al.: Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure. Am. J. PhysioL (1998) 274:H456–H466.
   PubMed Web of Science ®Google Scholar
• CITTADINI A, GROSSMAN JD, NAPOLI R et al.: Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J. Am. Coll. CardioL (1997) 29:1109–1116.
   PubMed Web of Science ®Google Scholar
• BUERKE M, MUROHARA T, SKURK C, et al.: Cardioprotective effect of insulin-like growth factor-I in myocardial ischemia followed by reperfitsion. Proc. NatL Acad. Sci. USA (1995) 92:8031–8035.
   Google Scholar
• SPINALE FG, HOUCK WV, PAN LC: Growth hormone supplementation with developing congestive heart failure: effects on left ventricular cellular structure and composition. Circulation (1998)98:180 (Suppl. I).
   Google Scholar
• TIMSIT J, RIOU B, BERTHERAT J et al.:Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern and myosin adenosine triphosphate activity of the rat left ventricle. J. Clin. Invest. (1990) 86:507–515.
   PubMed Web of Science ®Google Scholar
• KING MK, GAY DM, PAN LC et al.: Treatment with a growth hormone secretagogue in a model of developing heart failure. Effects on ventricular and myocyte function. Circulation (2001) 103:308–313.
   PubMed Web of Science ®Google Scholar
• O'DRISCOLL JG, GREEN DJ, IRELAND M et al.: Treatment of end-stage cardiac failure with growth hormone. Lancet (1997) 349:1068.
   Google Scholar
• ROMAN DL, BOBILLO ER: Reversing idiopathic dilated cardiomyopathy with growth hormone: is this possible? Ann. Int. Med. (1997) 126:834.
   Web of Science ®Google Scholar
• GENTH-ZOTZ S, ZOTZ R, GEIL S et al.: Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation (1999) 99:18–21.
   Google Scholar
• VOLTERRANI M, DESENZANI P, LORUSSO R et al.: Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet (1997) 349:1067–1068.
   PubMed Web of Science ®Google Scholar
• JOSE J, ZECHARIAH TU, GEORGE P: Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study. Ind. Heart J. (1999) 51:183–185.
   PubMedGoogle Scholar
• SPALLAROSSA P, ROSSETTIN P, MINUTO F et al.: Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease. Am. J. CardioL (1999) 84:430–433.
   PubMed Web of Science ®Google Scholar
• GIUSTINA A, VOLTERRANI M, MANELLI F, et al.: Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am. Heart J. (1999) 137:1035–1043.
   Google Scholar
• CAPALDO B, LEMBO G, RENDINA V et al.: Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur. Heart J. (1998) 19:623–627.
   PubMed Web of Science ®Google Scholar
• OSTERZIEL KJ, STROHM 0, SCHULER J et al.: Randomized, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet (1998) 351:1233–1237.
   Google Scholar
• PERROT A, RANKE MB, DIETZ R et aL:Growth hormone treatment in dilated cardiomyopathy. J. Card. Surg (2001) 16:127–131.
   PubMed Web of Science ®Google Scholar
• ISGAARD J, BERGH CH, CAIDAHL K et al.: A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur. Heart J. (1998) 19:1704–1711.
   PubMed Web of Science ®Google Scholar
• SMIT JWA, JANSSEN YJH, LAMB HJ et al.: Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J. Clin. EndocrinoL Metab. (2001) 86:4638–4643.
   PubMed Web of Science ®Google Scholar
• VAN THIEL SW, SMIT JWA, DE ROOS A et al.: Six-months of recombinant human GH therapy in patients with ischemic cardiac failure. Int. J. Cardiovasc. Imag. (2004) 20:53–60.
   Google Scholar
• ACEVADO M, CORBALÁN R, CHAMORRO G et al.: Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function exercise capacity, and neurohormonal status. Int. J. CardioL (2003) 87:185–191.
   PubMed Web of Science ®Google Scholar
• NAPOLI R, GUARDASOLE V, MATARAZZO M et al.: Growth hormone corrects vascular dysfunction in patients with chronic heart failure. J. Am. Coll. CardioL (2002) 39:90–95.
   PubMed Web of Science ®Google Scholar
• ADAMOPOULOS S, PARISSIS JT, GEORGIADIS M et al.: Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/ soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Am. Heart J. (2002) 144:359–64.
   PubMed Web of Science ®Google Scholar
• ADAMOPOULOS S, PARISSIS JT, PARASKEVAIDIS I et al.: Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur. Heart J. (2003) 24:2186-96. This study demonstrates the beneficial effects of GH treatment when it is prescribed in a pulsed fashion.
   Google Scholar
• TAKALA J, RUOKONEN E, WEBSTER NR et al.: Increased mortality associated with growth hormone treatment in critically ill adults. New Engl. J. Med. (1999) 341:785–792.
   PubMed Web of Science ®Google Scholar
• MATTER D, WALKER JL, ADAM E: Differential regulation by growth hormone (GH) of insulin-like growth factor 1 and GH receptor/binding protein gene expression in rat liver. Endocrinology (1992) 130:3257–3264.
   PubMed Web of Science ®Google Scholar
• ISGAARD J, CARLSSON L, ISAKSSON OG et al.: Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor-1 messanger ribonucleic acid more effectively than continuous GH infusion. Endocrinology (1988) 123:2605–2610.
   PubMed Web of Science ®Google Scholar
• ANKER SD, CHUA TP, PONIKOWSKI P et al.: Hormonal changes in catabolic/ anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 96:526–534.
   PubMed Web of Science ®Google Scholar
• ANKER SD, VOLTERRANI M, PFLAUM C-D et al.: Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J. Am. Coll. CardioL (2001) 38:443–452.
   PubMed Web of Science ®Google Scholar
• CICOIRA M, KALRA PR, ANKER SD: Growth hormone resistance in chronic heart failure and its therapeutic implications. J. Card. Fail. (2003) 9:219-226. An excellent review of GH resistance in HE
   Google Scholar
• NAGAYA N, KANGAWA K: Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Cur. Opin. PharmacoL (2003) 3:146–151.
   PubMed Web of Science ®Google Scholar
• KOJIMA M, HOSODA H, DATE Y et ell.:Ghrelin is a growth-hormone-releasing acylated peptidefrom stomach. Nature (1999) 402:656–660.
   Google Scholar
• NAGAYA N, KANGAWA K: Ghrelin, a novel growth hormone-releasing peptide in the treatment of chronic heart failure. ReguL Pept. (2003) 114:71–77.
   PubMed Web of Science ®Google Scholar
• LOCATELLI V, ROSSONI G, SCHWEIGER F et al.: Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology (1999) 140:4024–4031.
   PubMed Web of Science ®Google Scholar
• NAGAYA N, MORYA J, YASUMURA Y et al.: Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation (2004) 110:3674–3679.
   PubMed Web of Science ®Google Scholar
• JAYASANKAR V, PIROLLI T, BISH L et al.: Targetted overexpression of growth hormone by adeno viral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. j Mol. Cell. Cardiol. (2004) 36:531–538.
   PubMed Web of Science ®Google Scholar
• JAYASANKER V, BISH L, PIROLLI T et al.: Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function. Ann. Thorac. Surg. (2004) 77:2122–2129.
   PubMed Web of Science ®Google Scholar